Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) today announced that the U.S. Patent and Trademark Office (USPTO) has issued a U.S. Patent ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE